Sherine E. Gabriel, MD, MSc, has been named as the new president of Rush University. She will be its fourth president and the first solely focused on the University.
Using a new visually guided laser balloon device, cardiologists at Rush University Medical Center are able to more precisely treat cardiac arrhythmias causing atrial fibrillation.
Rush University Medical Center has received a $5 million donation from Chicago philanthropists Robert and Emily King that will accelerate blood cancer immunotherapy research and the development of new treatment options.
Mia Levy, MD, PhD, a breast cancer specialist and nationally recognized precision oncology leader, has been appointed director of the Rush University Cancer Center.
INSIGHT Into Diversity magazine has recognized Rush for diversity efforts in health professions higher education.
A new “metal-coordinated” drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
Rush is part of an initiative by U.S. Senator Richard Durbin to reduce violence in Chicago.
Adult patients who received liver and kidney transplants at Rush University Medical Center had better-than-expected survival rates one year later, according to a new report by the Scientific Registry of Transplant Recipients.
Rush University Medical Center ranked second among 99 academic medical centers in the United States in a study conducted by the health care services company Vizient.